Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Koopmans

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Therapeutic Drug Monitoring|August 15, 2000
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavirP W Hugen, D M Burger, M de Graaff, et al.
British Journal of Clinical Pharmacology|November 26, 2004
Effect of efavirenz treatment on the pharmacokinetics of nelfinavir boosted by ritonavir in healthy volunteersC J L la Porte, M J A de Graaff-Teulen, E P H Colbers, et al.
AIDS (London, England)|February 10, 1998
Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapyN A Foudraine, G J Weverling, T van Gool, et al.
The Journal of Infectious Diseases|June 1, 1994
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infectionP H Frissen, M E van der Ende, C H ten Napel, et al.
HIV Clinical Trials|November 25, 2005
Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES)S H Lowe, A M J Wensing, E A M Hassink, et al.
AIDS (London, England)|June 5, 1999
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)J W Cohen Stuart, R Schuurman, D M Burger, et al.
HIV Medicine|December 5, 2014
A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE studyH G Sprenger, N Langebeek, P G H Mulder, et al.
HIV Medicine|August 30, 2008
The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patientsC J P van den Bout-van den Beukel, M van den Bos, W J G Oyen, et al.
AIDS (London, England)|April 15, 1999
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study GroupN G Pakker, E D Kroon, M T Roos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 21, 2015
Acute hepatitis C in the Netherlands: characteristics of the epidemic in 2014S J Hullegie, G E L van den Berk, E M S Leyten, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Therapeutic Drug Monitoring|August 15, 2000
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavirP W Hugen, D M Burger, M de Graaff, et al.
British Journal of Clinical Pharmacology|November 26, 2004
Effect of efavirenz treatment on the pharmacokinetics of nelfinavir boosted by ritonavir in healthy volunteersC J L la Porte, M J A de Graaff-Teulen, E P H Colbers, et al.
AIDS (London, England)|February 10, 1998
Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapyN A Foudraine, G J Weverling, T van Gool, et al.
The Journal of Infectious Diseases|June 1, 1994
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infectionP H Frissen, M E van der Ende, C H ten Napel, et al.
HIV Clinical Trials|November 25, 2005
Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES)S H Lowe, A M J Wensing, E A M Hassink, et al.
AIDS (London, England)|June 5, 1999
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)J W Cohen Stuart, R Schuurman, D M Burger, et al.
HIV Medicine|December 5, 2014
A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE studyH G Sprenger, N Langebeek, P G H Mulder, et al.
HIV Medicine|August 30, 2008
The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patientsC J P van den Bout-van den Beukel, M van den Bos, W J G Oyen, et al.
AIDS (London, England)|April 15, 1999
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study GroupN G Pakker, E D Kroon, M T Roos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 21, 2015
Acute hepatitis C in the Netherlands: characteristics of the epidemic in 2014S J Hullegie, G E L van den Berk, E M S Leyten, et al.
Pageof 10